openPR Logo
Press release

Former US Diplomat Dr. Yonnas Kefle's New Book Examines Energy's Impact on Global Economy

04-23-2024 02:32 AM CET | Associations & Organizations

Press release from: ABNewswire

Former US Diplomat Dr. Yonnas Kefle's New Book Examines Energy's

Renowned economist and former US diplomat Dr. Yonnas Kefle is set to unveil his highly anticipated book, "Energy and the Political Economy of Nations," offering a compelling analysis of the world's energy landscape. From the dawn of humanity to the challenges of the modern era, Dr. Kefle's book explores the critical intersection of energy, economics, and the environment.

In "Energy and the Political Economy of Nations," Dr. Kefle guides readers through the historical examination of Earth's resources, highlighting the unsustainable practices that have resulted in the current energy crisis. Drawing from his diverse experiences as an economist and former U.S. diplomat, Dr. Kefle offers a comprehensive examination of the complexities surrounding fossil fuels, renewable energy, and the urgent need for a sustainable future.

"This book is a clarion call for change," says Dr. Kefle. "We are at a pivotal moment where we must reevaluate our relationship with energy and its profound impact on our planet," he added.

Through meticulous research and personal insights, Dr. Kefle navigates the geopolitics of energy, highlighting the global implications of climate change and advocating for international cooperation toward sustainable solutions. From energy poverty to the promise of renewable resources, the book equips readers with the knowledge to engage in crucial discussions on our shared energy future.

"Energy and the Political Economy of Nations" is a roadmap for policymakers, scholars, and concerned citizens alike. Join Dr. Yonnas Kefle as he unveils this groundbreaking book and explores the transformative potential of sustainable energy practices.

About the Author:

Dr. Yonnas Kefle, a distinguished economist and former U.S. diplomat, brings a wealth of experience to his upcoming book, "Energy and the Political Economy of Nations." Originally from Ethiopia, Dr. Kefle pursued his education in France and the United States, culminating in a Ph.D. in Economics from Howard University in Washington, D.C.. Additionally, Kefle is also the author of the book "Accidental American."

His professional journey includes roles as an economist at the U.S. Department of Labor's Bureau of Labor Statistics and later as a diplomat in the U.S. Department of State's Bureau of Western Hemisphere Affairs. It was during this time that Kefle's passion for energy was ignited by a childhood dream to electrify rural African communities that heavily relied on rudimentary energy sources like iron ores, charcoal, and kerosene.

Dr. Kefle's work in energy has been driven by a deep understanding of its impact on climate change and global warming. Having witnessed firsthand the devastating effects of climate change in his homeland and the broader Sahel region of Africa, as well as during his diplomatic tenure in the Caribbean, where he observed recurring hurricanes, earthquakes, ocean acidification, and a decline in marine biodiversity, Dr. Kefle is acutely aware of the urgent need for sustainable energy solutions.

His motivation for writing " Energy and the Political Economy of Nations" stems from a desire to highlight the ramifications of unchecked energy extraction and consumption on national economies and humanity's collective destiny. As fossil fuel-based energy resources dwindle and environmental repercussions intensify, Dr. Kefle's book serves as a timely call to action for a sustainable future.

For media inquiries, author interviews, or advance review copies, please contact:

Author's Name: Yonnas Kefle

Author's Email: yonnask@comcast.net

Author's Number: 1-301-385-2240

Media Contact
Company Name: New York Publishers
Contact Person: Yonnas Kefle
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=former-us-diplomat-dr-yonnas-kefles-new-book-examines-energys-impact-on-global-economy]
Phone: 1-301-385-2240
Address:445 Broad Hollow Rd
City: Melville
State: New York 11747
Country: United States
Website: https://www.nypublishers.co/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Former US Diplomat Dr. Yonnas Kefle's New Book Examines Energy's Impact on Global Economy here

News-ID: 3472442 • Views:

More Releases from ABNewswire

PD-1 and PD-L1 Inhibitors Market is expected to sour at a decent CAGR by 2020-2034, eatimates DelveInsight | Isunakinra, Dato-DXd, ONC-392, ZYNYZ (retifanlimab), Spartalizumab (PDR001), more
PD-1 and PD-L1 Inhibitors Market is expected to sour at a decent CAGR by 2020-20 …
PD-1 and PD-L1 inhibitor companies are Buzzard Pharmaceuticals, AstraZeneca, Daiichi Sankyo, Inc., OncoC4, Inc., BioNTech SE, Incyte, MacroGenics, Novartis, GlaxoSmithKline, Phanes Therapeutics, Compass Therapeutics, HUYABIO International, LLC., Bristol-Myers Squibb, Chugai Pharma USA, Bayer, Istari Oncology, Calico Life Sciences, AbbVie, NeoImmuneTech, Kartos Therapeutics, Inc., CellSight Technologies, Inc., Glenmark Specialty S.A., Jounce Therapeutics, Inc., Turnstone Biologics, and others. (Albany, USA) DelveInsight's PD-1 and PD-L1 Inhibitors Market Insights report includes a comprehensive understanding of
HDAC Inhibitor Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration, companies by DelveInsight | Givinostat, ACS 33, MG 4915, more
HDAC Inhibitor Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "HDAC Inhibitor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the HDAC Inhibitor Market. The HDAC Inhibitor Pipeline report embraces
TROP-2 Inhibitors Market to Grow at a decent CAGR during the Study Period (2020-2034) by DelveInsight | Datopotamab deruxtecan, MK-2870/SKB-264, DB-1305/BNT325, and BIO-106
TROP-2 Inhibitors Market to Grow at a decent CAGR during the Study Period (2020- …
TROP-2 inhibitor companies are Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech, BiOneCure Therapeutics, and others. (Albany, USA) DelveInsight's TROP-2 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, emerging TROP-2 inhibitors, market share of individual therapies, and current and forecasted TROP-2 inhibitors market size from 2020 to 2034, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan]. Key Takeaways
EGFR Inhibitors Market to Grow at a decent CAGR during the Study Period (2020-2034) by DelveInsight | Petosemtamab, MCLA-129, Zipalertinib, Furmonertinib, and BLU-945
EGFR Inhibitors Market to Grow at a decent CAGR during the Study Period (2020-20 …
EGFR inhibitor companies are Merus, Cullinan Oncology, Taiho Pharma, Arrivent Biopharma, Blueprint Medicines Corporation, and others. DelveInsight's EGFR Inhibitor Market Insights report includes a comprehensive understanding of current treatment practices, emerging EGFR inhibitors, market share of individual therapies, and current and forecasted EGFR Inhibitor market size from 2020 to 2034, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan]. Key Takeaways from the

All 5 Releases